| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GLOBUS MEDICAL INC | Director | Class A Common Stock | 16.4K | $1.15M | $70.00 | Jul 11, 2024 | Direct |
| ModivCare Inc | Director | Common Stock | 18.8K | $828K | $43.99 | Feb 14, 2024 | Direct |
| ARVINAS, INC. | Director | Common Stock | 10K | $471K | $47.05 | May 29, 2024 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Non-Qualified Stock Option | 2.98K | $219K | $73.60 | May 22, 2024 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 1.44K | $204K | $141.90 | May 22, 2024 | Direct |
| ARVINAS, INC. | Director | Stock Option (right to buy) | 9.07K | $145K | $16.00 | May 29, 2024 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Common Stock | 994 | $141K | $141.82 | May 17, 2024 | Direct |
| CENTENE CORP | Director | Common Stock | 1.48K | $113K | $76.60 | Mar 31, 2022 | Direct |
| GLOBUS MEDICAL INC | Director | Stock Option (Right to Buy Class A Common Stock) | 15K | Jan 26, 2024 | Direct | ||
| CENTENE CORP | Director | Common Stock Option (right to buy) | 10K | Mar 31, 2022 | Direct | ||
| MAGELLAN HEALTH INC | Director | Ordinary Common Stock, $0.01 par value | 0 | $94.99 | Jan 4, 2022 | Direct | |
| NUVASIVE INC | Director | Common Stock, par value $0.001 per share | 0 | $42.67 | Sep 1, 2023 | Direct | |
| NUVASIVE INC | Director | Restricted Stock | 0 | Sep 1, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GMED | GLOBUS MEDICAL INC | Jul 11, 2024 | 1 | -$70K | 4 | Jul 15, 2024 | Director |
| ARVN | ARVINAS, INC. | May 29, 2024 | 2 | $0 | 4 | May 31, 2024 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 22, 2024 | 2 | $0 | 4 | May 23, 2024 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2024 | 3 | -$157K | 4 | May 21, 2024 | Director |
| GMED | GLOBUS MEDICAL INC | Mar 15, 2024 | 1 | -$551K | 4 | Mar 19, 2024 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | Feb 27, 2024 | 3 | -$1.09M | 4 | Feb 29, 2024 | Director |
| MODV | ModivCare Inc | Feb 14, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Director |
| GMED | GLOBUS MEDICAL INC | Jan 26, 2024 | 1 | $0 | 4 | Jan 30, 2024 | Director |
| GMED | GLOBUS MEDICAL INC | Sep 1, 2023 | 3 | $0 | 4 | Sep 6, 2023 | Director |
| GMED | GLOBUS MEDICAL INC | Sep 1, 2023 | 0 | $0 | 3 | Sep 6, 2023 | Director |
| NUVA | NUVASIVE INC | Sep 1, 2023 | 11 | $0 | 4 | Sep 5, 2023 | Director |
| ARVN | ARVINAS, INC. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | Director |
| NUVA | NUVASIVE INC | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
| MODV | ModivCare Inc | Feb 16, 2023 | 1 | $0 | 4 | Feb 21, 2023 | Director |
| ARVN | ARVINAS, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| NUVA | NUVASIVE INC | Jun 1, 2022 | 2 | $0 | 4 | Jun 1, 2022 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| NUVA | NUVASIVE INC | May 11, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
| CNC | CENTENE CORP | Mar 31, 2022 | 1 | $31.3K | 4 | Apr 4, 2022 | Director |
| MODV | ModivCare Inc | Feb 7, 2022 | 1 | $0 | 4 | Feb 9, 2022 | Director |
| CNC | CENTENE CORP | Feb 7, 2022 | 2 | $0 | 4 | Feb 9, 2022 | Director |
| CNC | CENTENE CORP | Jan 11, 2022 | 0 | $0 | 3 | Jan 18, 2022 | Director |
| MGLN | MAGELLAN HEALTH INC | Jan 4, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director |
| MGLN | MAGELLAN HEALTH INC | Aug 13, 2021 | 1 | $0 | 4 | Aug 13, 2021 | Director |
| ARVN | ARVINAS, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| NUVA | NUVASIVE INC | Jun 1, 2021 | 2 | $0 | 4 | Jun 3, 2021 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |
| NUVA | NUVASIVE INC | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |